Investigation on Ranbaxy Quality Issue Ends, Risks Eliminated: Daiichi Sankyo Pres.

May 15, 2013
Daiichi Sankyo President Joji Nakayama Daiichi Sankyo said on May 14 that an investigation by the US Department of Justice into data integrity and manufacturing processes at Indian subsidiary Ranbaxy Laboratories has been concluded. “The specific risks that have been...read more